Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

CXCR4-targeted sorafenib-loaded DOPA/TPGS-PLGA nanoparticles

Based on

1 Articles
2015 Most recent source

Composition

1

poly(lactic-co-glycolic acid)

PLGA
Type Polymer
Formula
Role core
2

D-α-tocopheryl polyethylene glycol 1000 succinate

TPGS
Type Polymer
Formula
Role layer
3

dioleoylphosphatydic acid

dioleoylphosphatydic acid DOPA
Type Single Compound
Formula C39H73O8P
Role layer
4

plerixafor

AMD3100
Type Single Compound
Formula C28H54N8
Role layer
5

4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide

sorafenib SFN SOR SF
Type Single Compound
Formula C21H16ClF3N4O3
Role loaded material

Properties

General physical and chemical properties

Property Value Source
drug release dependent on pH

1 more entry available to subscribers only.

Or, view sample content

Applications

Area Application Source
medicine/veterinary

0 more entry available to subscribers only.

Or, view sample content

Characterization

Method Source
dynamic light scattering

1 more entry available to subscribers only.

Or, view sample content

Biological effects

Biological system Test details Source
C3H/HeNCrNarl mouse bearing HCA-1 tumor

3 more entries available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide
  • D-α-tocopheryl polyethylene glycol 1000 succinate
  • dioleoylphosphatydic acid
See all (4)
  1. 7b9c
Product

CXCR4-targeted sorafenib-loaded DOPA/TPGS-PLGA nanoparticles

Method 2

Type: Physical formation
Source:
Product

CXCR4-targeted sorafenib-loaded DOPA/TPGS-PLGA nanoparticles

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial